MDT

87.11

-0.93%↓

115.09

-0.3%↓

VEEV

151.46

-3.57%↓

HQY

78.12

-6.83%↓

TLRY

6.58

-1.94%↓

MDT

87.11

-0.93%↓

115.09

-0.3%↓

VEEV

151.46

-3.57%↓

HQY

78.12

-6.83%↓

TLRY

6.58

-1.94%↓

MDT

87.11

-0.93%↓

115.09

-0.3%↓

VEEV

151.46

-3.57%↓

HQY

78.12

-6.83%↓

TLRY

6.58

-1.94%↓

MDT

87.11

-0.93%↓

115.09

-0.3%↓

VEEV

151.46

-3.57%↓

HQY

78.12

-6.83%↓

TLRY

6.58

-1.94%↓

MDT

87.11

-0.93%↓

115.09

-0.3%↓

VEEV

151.46

-3.57%↓

HQY

78.12

-6.83%↓

TLRY

6.58

-1.94%↓

Home・Aktien・Vivani Medical

Vivani Medical

Geschlossen

1.03 -0.96

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

1.02

Max

1.03

Schlüsselkennzahlen
By Trading Economics
Einkommen	-103K -6.6M
Angestellte	37

Empfehlungen
By TipRanks
Empfehlungen	Buy
12-Monats-Prognose	+260.58% upside

Dividenden
By Dow Jones
Nächstes Ergebnis	11. Mai 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	-4.9M 68M
Vorheriger Eröffnungskurs	1.99
Vorheriger Schlusskurs	1.03

Vivani Medical Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

10. Apr. 2026, 17:04 UTC

Wichtige Markttreiber

FDA Rejects Replimune's Melanoma Drug for a Second Time

11. Apr. 2026, 00:00 UTC

Ergebnisse

Akquisitionen, Fusionen, Übernahmen

Big Yachts, Big Bucks -- Barrons.com

10. Apr. 2026, 21:55 UTC

Akquisitionen, Fusionen, Übernahmen

Paramount Warrants Are an Underappreciated Aspect of Warner Bros. Deal -- Barrons.com

10. Apr. 2026, 21:01 UTC

Ergebnisse

Cango Inc.: Files Annual Report on Form 20-F With SEC

10. Apr. 2026, 20:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

10. Apr. 2026, 20:50 UTC

Market Talk

Wichtige Nachrichtenereignisse

Basic Materials Roundup: Market Talk

10. Apr. 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

10. Apr. 2026, 20:31 UTC

Market Talk

Convenience Store Traffic Slows as Gas Prices Rise -- Market Talk

10. Apr. 2026, 20:10 UTC

Akquisitionen, Fusionen, Übernahmen

This Women's Health Company Is Drawing Takeover Interest. The Stock Is Soaring. -- Barrons.com

10. Apr. 2026, 19:15 UTC

Market Talk

Global Energy Roundup: Market Talk

10. Apr. 2026, 19:15 UTC

Market Talk

Oil Futures Settle Lower With Focus on U.S.-Iran Talks -- Market Talk

10. Apr. 2026, 19:08 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

10. Apr. 2026, 19:08 UTC

Market Talk

U.S. Natural Gas Futures End Week Lower -- Market Talk

10. Apr. 2026, 18:38 UTC

Market Talk

Canada's Job Market Showing Soft Demand, Structural Decline in Supply -- Market Talk

10. Apr. 2026, 18:25 UTC

Market Talk

Wichtige Nachrichtenereignisse

Precious Metals Finish With Weekly Gains -- Market Talk

10. Apr. 2026, 18:05 UTC

Market Talk

Rising Commodity Prices Seen Carrying More Weight Than Jobs Data for Bank of Canada Watchers -- Market Talk

10. Apr. 2026, 17:31 UTC

Market Talk

Wichtige Nachrichtenereignisse

U.S. Oil Rig Count Unchanged This Week At 411 -- Market Talk

10. Apr. 2026, 17:26 UTC

Ergebnisse

Big Banks' Profits Set to Rise Even as 'Wall of Worry' Looms -- Barrons.com

10. Apr. 2026, 17:10 UTC

Market Talk

White House Defense of Stablecoin Yields Is Welcome Move, Grayscale Says -- Market Talk

10. Apr. 2026, 17:00 UTC

Wichtige Nachrichtenereignisse

Construction Business Taking a Hit From Iran Conflict -- WSJ

10. Apr. 2026, 16:20 UTC

Market Talk

Health Care Roundup: Market Talk

10. Apr. 2026, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

10. Apr. 2026, 16:12 UTC

Ergebnisse

Partners Group CEO: Group Well Positioned to Navigate Current Complex Environment

10. Apr. 2026, 16:11 UTC

Ergebnisse

Partners Group: Traditional Programs Contributed $3.3B

10. Apr. 2026, 16:10 UTC

Ergebnisse

Partners Group: $5B of New Commitments Came From Bespoke Solutions

10. Apr. 2026, 16:10 UTC

Ergebnisse

Partners Group: That Is Across All Private Markets Asset Classes and Client Strategies

10. Apr. 2026, 16:10 UTC

Ergebnisse

Partners Group 1Q New Client Demand $8.3B

10. Apr. 2026, 16:09 UTC

Ergebnisse

Partners Group Continued to See Positive Fundraising Momentum in 1Q

10. Apr. 2026, 15:54 UTC

Akquisitionen, Fusionen, Übernahmen

Plenitude Completes Acquisition of Acea Energia

10. Apr. 2026, 15:38 UTC

Market Talk

Global Energy Roundup: Market Talk

Peer-Vergleich

Kursveränderung

Vivani Medical Prognose

Kursziel

By TipRanks

260.58% Vorteil

12-Monats-Prognose

Durchschnitt 3.75 USD 260.58%

Hoch 4 USD

Tief 3.5 USD

Basierend auf 2 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Vivani Medical – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

2 ratings

Buy

Halten

Sell

Basierend auf 2 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Vivani Medical – Dist abgegeben haben.

Finanzen

Vertriebs- und Verwaltungskosten

Gewinn vor Steuern

Verkäufe

Betriebsergebnis

Über Vivani Medical

Vivani Medical, Inc., a preclinical stage biopharmaceutical company, engages in the development of miniaturized and subdermal implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease, medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in preclinical stage development for the treatment of chronic weight management in patients with obesity or overweight; NPM-119, an exenatide implant candidate is in preclinical stage development for the treatment of patients with type 2 diabetes; NPM-139, a miniature, subdermal GLP-1 implant in development for chronic weight management; and OKV-119, an exenatide implant is under development for metabolic diseases in cats including for the treatment of obesity and diabetes. The company is headquartered in Alameda, California.